Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mersana Therapeutics, Inc. | Director | Common Stock | 125K | $339K | $2.71 | Jan 16, 2024 | Direct |
Nuvalent, Inc. | Director | Class A Common Stock | 2.5K | $206K | $82.33 | Jun 12, 2024 | Direct |
Mersana Therapeutics, Inc. | Director | Common Stock | 72.3K | $196K | $2.71 | Jan 13, 2024 | By Trust |
Dicerna Pharmaceuticals Inc | Director | Common Stock | 3.33K | $127K | $38.25 | Jun 3, 2021 | Direct |
Mersana Therapeutics, Inc. | Director | Stock Option (right to buy) | 55K | Jun 11, 2024 | Direct | ||
Nuvalent, Inc. | Director | Stock Option (Right to Buy) | 3.79K | Jun 12, 2024 | Direct | ||
Dicerna Pharmaceuticals Inc | Director | Restricted Stock Units | 0 | Jun 3, 2021 | Direct | ||
Mersana Therapeutics, Inc. | Director | Restricted Stock Unit | 0 | $2.71 | Jan 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NUVL | Nuvalent, Inc. | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
MRSN | Mersana Therapeutics, Inc. | Jun 11, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
MRSN | Mersana Therapeutics, Inc. | Jan 13, 2024 | 9 | -$79.7K | 4 | Jan 17, 2024 | Director |
NUVL | Nuvalent, Inc. | Dec 18, 2023 | 3 | -$332K | 4 | Dec 20, 2023 | Director |
MRSN | Mersana Therapeutics, Inc. | Sep 11, 2023 | 2 | $0 | 4 | Sep 13, 2023 | Director |
NUVL | Nuvalent, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
MRSN | Mersana Therapeutics, Inc. | Jan 13, 2023 | 11 | -$99.6K | 4 | Jan 18, 2023 | President & CEO, Director |
NUVL | Nuvalent, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
NUVL | Nuvalent, Inc. | Mar 30, 2022 | 1 | $0 | 4 | Mar 31, 2022 | Director |
NUVL | Nuvalent, Inc. | Mar 30, 2022 | 0 | $0 | 3 | Mar 31, 2022 | Director |
MRSN | Mersana Therapeutics, Inc. | Jan 14, 2022 | 5 | $0 | 4 | Jan 19, 2022 | President & CEO, Director |
MRSN | Mersana Therapeutics, Inc. | Jul 15, 2021 | 4 | -$513K | 4 | Jul 19, 2021 | President & CEO, Director |
DRNA | Dicerna Pharmaceuticals Inc | Jun 3, 2021 | 2 | $0 | 4 | Jun 7, 2021 | Director |